Literature DB >> 33210482

[Analysis of GFM1 gene mutations in a family with combined oxidative phosphorylation deficiency 1].

Yaping Shen1, Kai Yan2, Minyue Dong2, Rulai Yang1, Xinwen Huang1.   

Abstract

OBJECTIVE: To analyze the clinical phenotype and genetic characteristics of a family with combined oxidative phosphorylation deficiency 1 (COXPD-1).
METHODS: The whole exome sequencing was performed in parents of the proband; and the genetic defects were verified by Sanger sequencing technology in the dried blood spot of the proband, the amniotic fluid sample of the little brother of proband, and the peripheral blood of the parents.
RESULTS: Whole exome sequencing and Sanger validation showed compound heterozygous mutations of GFM1 gene c.688G>A(p.G230S) and c.1576C>T (p.R526X) in both the proband and her little brother, and the c.1576C>T of GFM1 variant was first reported. The two patients were died in early infancy, and presented with metabolic acidosis, high lactic acid, abnormal liver function, feeding difficulties, microcephaly, development retardation and epilepsy.
CONCLUSIONS: GFM1 gene c.688G>A and c.1576C>T compound heterozygous mutations are the cause of this family of COXPD-1.

Entities:  

Keywords:  Combined oxidative phosphorylation deficiency 1; Congenital, hereditary, and neonatal diseases and abnormalities; GFM1 gene; Metabolic acidosis; Whole exome sequencing

Mesh:

Substances:

Year:  2020        PMID: 33210482      PMCID: PMC8800753          DOI: 10.3785/j.issn.1008-9292.2020.10.04

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  16 in total

1.  The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1.

Authors:  Hana Antonicka; Florin Sasarman; Nancy G Kennaway; Eric A Shoubridge
Journal:  Hum Mol Genet       Date:  2006-04-21       Impact factor: 6.150

2.  Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing.

Authors:  Sarah E Calvo; Alison G Compton; Steven G Hershman; Sze Chern Lim; Daniel S Lieber; Elena J Tucker; Adrienne Laskowski; Caterina Garone; Shangtao Liu; David B Jaffe; John Christodoulou; Janice M Fletcher; Damien L Bruno; Jack Goldblatt; Salvatore Dimauro; David R Thorburn; Vamsi K Mootha
Journal:  Sci Transl Med       Date:  2012-01-25       Impact factor: 17.956

3.  Infantile Progressive Hepatoencephalomyopathy with Combined OXPHOS Deficiency due to Mutations in the Mitochondrial Translation Elongation Factor Gene GFM1.

Authors:  S Balasubramaniam; Y S Choy; A Talib; M D Norsiah; L P van den Heuvel; R J Rodenburg
Journal:  JIMD Rep       Date:  2011-12-21

4.  Toward genotype phenotype correlations in GFM1 mutations.

Authors:  Louise Galmiche; Valérie Serre; Marine Beinat; Raïssa Zossou; Zahra Assouline; Anne-Sophie Lebre; Florence Chretien; Ruthie Shenhav; Avraham Zeharia; Ann Saada; Vanessa Vedrenne; Nathalie Boddaert; Pascale de Lonlay; Marlène Rio; Arnold Munnich; Agnès Rötig
Journal:  Mitochondrion       Date:  2011-10-01       Impact factor: 4.160

5.  Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency.

Authors:  Mariella T Simon; Bobby G Ng; Marisa W Friederich; Raymond Y Wang; Monica Boyer; Martin Kircher; Renata Collard; Kati J Buckingham; Richard Chang; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Johan L K Van Hove; Hudson H Freeze; Jose E Abdenur
Journal:  Mitochondrion       Date:  2017-02-12       Impact factor: 4.160

6.  Cloning and characterization of human and mouse mitochondrial elongation factor G, GFM and Gfm, and mapping of GFM to human chromosome 3q25.1-q26.2.

Authors:  J Gao; L Yu; P Zhang; J Jiang; J Chen; J Peng; Y Wei; S Zhao
Journal:  Genomics       Date:  2001-05-15       Impact factor: 5.736

7.  Clinical, neuroimaging and biochemical findings in patients and patient fibroblasts expressing ten novel GFM1 mutations.

Authors:  Giulia Barcia; Marlène Rio; Zahra Assouline; Coralie Zangarelli; Naig Gueguen; Valerie D Dumas; Pascale Marcorelles; Manuel Schiff; Abdelhamid Slama; Magalie Barth; Marie Hully; Pascale de Lonlay; Arnold Munnich; Isabelle Desguerre; Jean-Paul Bonnefont; Julie Steffann; Vincent Procaccio; Nathalie Boddaert; Agnès Rötig; Metodi D Metodiev; Benedetta Ruzzenente
Journal:  Hum Mutat       Date:  2019-11-11       Impact factor: 4.878

8.  Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu.

Authors:  Lucia Valente; Valeria Tiranti; Rene Massimiliano Marsano; Edoardo Malfatti; Erika Fernandez-Vizarra; Claudia Donnini; Paolo Mereghetti; Luca De Gioia; Alberto Burlina; Claudio Castellan; Giacomo P Comi; Salvatore Savasta; Iliana Ferrero; Massimo Zeviani
Journal:  Am J Hum Genet       Date:  2006-11-15       Impact factor: 11.025

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  The International Mouse Phenotyping Consortium Web Portal, a unified point of access for knockout mice and related phenotyping data.

Authors:  Gautier Koscielny; Gagarine Yaikhom; Vivek Iyer; Terrence F Meehan; Hugh Morgan; Julian Atienza-Herrero; Andrew Blake; Chao-Kung Chen; Richard Easty; Armida Di Fenza; Tanja Fiegel; Mark Grifiths; Alan Horne; Natasha A Karp; Natalja Kurbatova; Jeremy C Mason; Peter Matthews; Darren J Oakley; Asfand Qazi; Jack Regnart; Ahmad Retha; Luis A Santos; Duncan J Sneddon; Jonathan Warren; Henrik Westerberg; Robert J Wilson; David G Melvin; Damian Smedley; Steve D M Brown; Paul Flicek; William C Skarnes; Ann-Marie Mallon; Helen Parkinson
Journal:  Nucleic Acids Res       Date:  2013-11-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.